​

Funding Round

Venture Round - Artax Biopharma

Venture Round - Artax Biopharma

Investment Firm

Overview

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Announced Date

May 11, 2022

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorSound Bioventures
Participant InvestorColumbus Venture Partners
Participant InvestorEli Lilly
Participant InvestorAdvent Life Sciences

Round Details and Background

Artax Biopharma raised $26000000 on 2022-05-11 in Venture Round

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 06, 2024
Convertible Note - Artax Biopharma
5-8.0M
Sep 22, 2015
Series B - Artax Biopharma
2-10.0M
Oct 12, 2014
Series A - Artax Biopharma
1-2.0M
Sep 26, 2013
Venture Round - Artax Biopharma
-1.3M

Recent Activity

There is no recent news or activity for this profile.